Literature DB >> 21697586

A new 13C breath test to detect vitamin B12 deficiency: a prevalent and poorly diagnosed health problem.

David A Wagner1, Richard Schatz, Richard Coston, Cheryl Curington, Daniel Bolt, Phillip P Toskes.   

Abstract

Vitamin B12 deficiency is emerging as a growing public health problem. The most commonly used diagnostic tests are limited in accuracy, sensitivity, and are non-specific for B12 deficiency. The aim of this study was to develop a simple B12 breath test (BBT) to more accurately evaluate vitamin B12 status as an alternative to the most common diagnostic test, serum B12 levels. The breath test is based on the metabolism of sodium 1-(13)C-propionate to (13)CO(2) which requires B12 as a cofactor. We initially compared the BBT to current B12 diagnostic methods in 58 subjects. Subjects also received a second BBT 1-3 days after initial testing to evaluate reproducibility of results. Propionate dosage, fasting times, and collection periods were compared, respectively. The dose of sodium 1-(13)C-propionate (10-50 mg) gave equivalent results while an 8 h fast was essential. Statistical analysis revealed that breath collection times could be reduced to just a baseline and 10 and 20 min following propionate dosing. We also measured the incidence of B12 deficiency with the BBT in 119 patients with chronic pancreatitis, Crohn's disease, small intestinal bacterial overgrowth, and subjects over 65 years of age. The BBT results agreed with previous publications showing a higher incidence of B12 deficiency in these patients. The BBT may provide clinicians with a non-invasive, accurate, reliable, and reproducible diagnostic test to detect vitamin B12 deficiency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697586      PMCID: PMC3204151          DOI: 10.1088/1752-7155/5/4/046001

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  21 in total

Review 1.  Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician.

Authors:  C F Snow
Journal:  Arch Intern Med       Date:  1999-06-28

2.  Plasma vitamin B-12 concentrations relate to intake source in the Framingham Offspring study.

Authors:  K L Tucker; S Rich; I Rosenberg; P Jacques; G Dallal; P W Wilson; J Selhub
Journal:  Am J Clin Nutr       Date:  2000-02       Impact factor: 7.045

3.  Vitamin B-12 and homocysteine status among vegetarians: a global perspective.

Authors:  Ibrahim Elmadfa; Ingrid Singer
Journal:  Am J Clin Nutr       Date:  2009-04-08       Impact factor: 7.045

4.  Clinical spectrum and diagnosis of cobalamin deficiency.

Authors:  S P Stabler; R H Allen; D G Savage; J Lindenbaum
Journal:  Blood       Date:  1990-09-01       Impact factor: 22.113

5.  Screening for vitamin B12 deficiency: caveat emptor.

Authors:  R Green
Journal:  Ann Intern Med       Date:  1996-03-01       Impact factor: 25.391

Review 6.  Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B(12) and folate.

Authors:  G G Klee
Journal:  Clin Chem       Date:  2000-08       Impact factor: 8.327

7.  Propionylcarnitine excretion is not affected by metronidazole administration to patients with disorders of propionate metabolism.

Authors:  S P Burns; R A Iles; J M Saudubray; R A Chalmers
Journal:  Eur J Pediatr       Date:  1996-01       Impact factor: 3.183

8.  Methylmalonic acid measured in plasma and urine by stable-isotope dilution and electrospray tandem mass spectrometry.

Authors:  M J Magera; J K Helgeson; D Matern; P Rinaldo
Journal:  Clin Chem       Date:  2000-11       Impact factor: 8.327

9.  Energy equivalents of CO2 and their importance in assessing energy expenditure when using tracer techniques.

Authors:  M Elia
Journal:  Am J Physiol       Date:  1991-01

10.  Screening elderly populations for cobalamin (vitamin B12) deficiency using the urinary methylmalonic acid assay by gas chromatography mass spectrometry.

Authors:  E J Norman; J A Morrison
Journal:  Am J Med       Date:  1993-06       Impact factor: 4.965

View more
  4 in total

Review 1.  Anaemia in inflammatory bowel disease.

Authors:  Martyn Dibb; Sreedhar Subramanian
Journal:  Frontline Gastroenterol       Date:  2014-01-03

2.  Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors.

Authors:  E M Dunbar; B S Coats; A L Shroads; T Langaee; A Lew; J R Forder; J J Shuster; D A Wagner; P W Stacpoole
Journal:  Invest New Drugs       Date:  2013-12-03       Impact factor: 3.850

3.  Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties.

Authors:  Anton Amann; Pawel Mochalski; Vera Ruzsanyi; Yoav Y Broza; Hossam Haick
Journal:  J Breath Res       Date:  2014-02-24       Impact factor: 3.262

4.  1-13C-propionate breath testing as a surrogate endpoint to assess efficacy of liver-directed therapies in methylmalonic acidemia (MMA).

Authors:  Irini Manoli; Alexandra R Pass; Elizabeth A Harrington; Jennifer L Sloan; Jack Gagné; Samantha McCoy; Sarah L Bell; Jacob D Hattenbach; Brooks P Leitner; Courtney J Duckworth; Laura A Fletcher; Thomas M Cassimatis; Carolina I Galarreta; Audrey Thurm; Joseph Snow; Carol Van Ryzin; Susan Ferry; Nicholas Ah Mew; Oleg A Shchelochkov; Kong Y Chen; Charles P Venditti
Journal:  Genet Med       Date:  2021-04-05       Impact factor: 8.822

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.